Free tool
Drug Trial Radar: Gastroenterology and liver
Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
1
Active, not recruiting, industry sponsors, Gastroenterology and liver, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
1 trial
Showing 1 to 1, recently updated first.
SanofiSanofi (SNY)
NCT06101095 · 69 participants · Start Nov 29, 2023 · Primary completion Nov 5, 2025
Drug: Dupilumab; Placebo · For: Eosinophilic Oesophagitis
Sites: Murrieta, California; San Francisco, California; Jacksonville, Florida · 30 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.